Literature DB >> 27088131

Factor Analysis of the DePaul Symptom Questionnaire: Identifying Core Domains.

Leonard A Jason1, Madison Sunnquist1, Abigail Brown1, Jacob Furst1, Marjoe Cid1, Jillianna Farietta1, Bobby Kot1, Craig Bloomer1, Laura Nicholson1, Yolonda Williams1, Rachel Jantke1, Julia L Newton2, Elin Bolle Strand3.   

Abstract

The present study attempted to identify critical symptom domains of individuals with Myalgic Encephalomyelitis (ME) and chronic fatigue syndrome (CFS). Using patient and control samples collected in the United States, Great Britain, and Norway, exploratory factor analysis (EFA) was used to establish the underlying factor structure of ME and CFS symptoms. The EFA suggested a four-factor solution: post-exertional malaise, cognitive dysfunction, sleep difficulties, and a combined factor consisting of neuroendocrine, autonomic, and immune dysfunction symptoms. The use of empirical methods could help better understand the fundamental symptom domains of this illness.

Entities:  

Keywords:  Case definition; Chronic fatigue syndrome; DePaul symptom questionnaire; Myalgic encephalomyelitis

Year:  2015        PMID: 27088131      PMCID: PMC4830389          DOI: 10.16966/2379-7150.114

Source DB:  PubMed          Journal:  J Neurol Neurobiol        ISSN: 2379-7150


  19 in total

1.  Fatigue Scales and Chronic Fatigue Syndrome: Issues of Sensitivity and Specificity.

Authors:  Leonard A Jason; Meredyth Evans; Molly Brown; Nicole Porter; Abigail Brown; Jessica Hunnell; Valerie Anderson; Athena Lerch
Journal:  Disabil Stud Q       Date:  2011

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome.

Authors:  P De Becker; N McGregor; K De Meirleir
Journal:  J Intern Med       Date:  2001-09       Impact factor: 8.989

4.  Factor analysis of the Beck Depression Inventory-II with patients with chronic fatigue syndrome.

Authors:  Molly Brown; Carly Kaplan; Leonard Jason
Journal:  J Health Psychol       Date:  2011-11-21

5.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

6.  A community-based study of chronic fatigue syndrome.

Authors:  L A Jason; J A Richman; A W Rademaker; K M Jordan; A V Plioplys; R R Taylor; W McCready; C F Huang; S Plioplys
Journal:  Arch Intern Med       Date:  1999-10-11

7.  Test-Retest Reliability of the DePaul Symptom Questionnaire.

Authors:  Leonard A Jason; Suzanna So; Abigail A Brown; Madison Sunnquist; Meredyth Evans
Journal:  Fatigue       Date:  2015-01-08

Review 8.  Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings?

Authors:  Ian Hickie; Tracey Davenport; Suzanne D Vernon; Rosane Nisenbaum; William C Reeves; Dusan Hadzi-Pavlovic; Andrew Lloyd
Journal:  Aust N Z J Psychiatry       Date:  2009-01       Impact factor: 5.744

9.  Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome?

Authors:  Rosane Nisenbaum; Michele Reyes; Elizabeth R Unger; William C Reeves
Journal:  J Psychosom Res       Date:  2004-02       Impact factor: 3.006

10.  Chronic Fatigue Syndrome versus Systemic Exertion Intolerance Disease.

Authors:  Leonard A Jason; Madison Sunnquist; Abigail Brown; Julia L Newton; Elin Bolle Strand; Suzanne D Vernon
Journal:  Fatigue       Date:  2015-07
View more
  17 in total

1.  Subtyping Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) By Course of Illness.

Authors:  Jamie Stoothoff; Kristen Gleason; Stephanie McManimen; Taylor Thorpe; Leonard A Jason
Journal:  J Biosens Biomark Diagn       Date:  2017-06-26

2.  The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Kyle W Murdock; Xin Shelley Wang; Qiuling Shi; Charles S Cleeland; Christopher P Fagundes; Suzanne D Vernon
Journal:  Qual Life Res       Date:  2016-09-06       Impact factor: 4.147

3.  Deconstructing post-exertional malaise: An exploratory factor analysis.

Authors:  Stephanie L McManimen; Madison L Sunnquist; Leonard A Jason
Journal:  J Health Psychol       Date:  2016-08-24

4.  Meta-analysis investigating post-exertional malaise between patients and controls.

Authors:  Abigail Brown; Leonard A Jason
Journal:  J Health Psychol       Date:  2018-07-05

5.  The development of a short form of the DePaul Symptom Questionnaire.

Authors:  Madison Sunnquist; Savitri Lazarus; Leonard A Jason
Journal:  Rehabil Psychol       Date:  2019-07-18

6.  Effects of Chronic Diurnal Disruption and Acute Inflammatory Challenge on Mice with Latent Murine Gammaherpesvirus Infection.

Authors:  Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

7.  The DePaul Symptom Questionnaire-2: A Validation Study.

Authors:  Helen Bedree; Madison Sunnquist; Leonard A Jason
Journal:  Fatigue       Date:  2019-08-12

8.  Latent class analysis of a heterogeneous international sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Kayla A Huber; Madison Sunnquist; Leonard A Jason
Journal:  Fatigue       Date:  2018-07-04

9.  Myalgic encephalomyelitis and chronic fatigue syndrome case definitions: effects of requiring a substantial reduction in functioning.

Authors:  Samantha Scartozzi; Madison Sunnquist; Leonard A Jason
Journal:  Fatigue       Date:  2019-04-01

10.  The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome.

Authors:  Leonard A Jason; Carly S Holtzman; Madison Sunnquist; Joseph Cotler
Journal:  J Health Psychol       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.